Voxcell BioInnovation Inc.
New Form D on file · 2025-03-24 · the record
Before you sell to, join or invest in Voxcell BioInnovation Inc.
MentionFox check on Voxcell BioInnovation Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/voxcell-bioinnovation-inc-form-d-25000001
Check Voxcell BioInnovation Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Voxcell BioInnovation Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Voxcell BioInnovation Inc. filed a Form D with the Securities and Exchange Commission on 2025-03-24.
Voxcell BioInnovation Inc. filed a Form D notice of an exempt securities offering with the SEC on March 24, 2025. The filing reports $1.73M sold. Its industry group is Biotechnology. It names Karolina Valente (Executive Officer, Director), Nina Vellani (Director), Robert Levak (Director) (SEC Form D, March 24, 2025).
Is this your company?
Sell to companies like Voxcell BioInnovation Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-24 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Voxcell BioInnovation Inc.
Free to see. No signup.
More on the people and the money behind Voxcell BioInnovation Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Voxcell BioInnovation Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Voxcell BioInnovation Inc. raises, hires or launches. No email unless you switch it on.
Watch Voxcell BioInnovation Inc. →Get the full cited report on Voxcell BioInnovation Inc.
What the filing shows about Voxcell BioInnovation Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Voxcell BioInnovation Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Voxcell BioInnovation Inc.'s address as 300-637 Bay Street, Victoria, A1 V8T 5L2.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Voxcell BioInnovation Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Voxcell BioInnovation Inc. See pricing
Voxcell BioInnovation Inc. is a registered filer with the SEC (CIK 2041826) and has filed since 2024-11-18. 3 filings are on record, the latest on 2026-09-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Voxcell BioInnovation Inc.'s Form D of 2025-03-24 names Karolina Valente, Nina Vellani, Robert Levak and 2 more as its officers, directors or promoters.
Its new offerings report $5.47M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Karolina Valente is named as Executive Officer and Director on the Form D that Voxcell BioInnovation Inc. filed with the SEC on 24 March 2025, one of 5 people that filing names.
Nina Vellani is named as Director on the Form D that Voxcell BioInnovation Inc. filed with the SEC on 24 March 2025, one of 5 people that filing names.
Robert Levak is named as Director on the Form D that Voxcell BioInnovation Inc. filed with the SEC on 24 March 2025, one of 5 people that filing names.
Qi Fang is named as Director on the Form D that Voxcell BioInnovation Inc. filed with the SEC on 24 March 2025, one of 5 people that filing names.
Mark Miller is named as Director on the Form D that Voxcell BioInnovation Inc. filed with the SEC on 24 March 2025, one of 5 people that filing names.
5 people named on the filing — 1 holding an executive role and 4 as directors only.
Named as of the 2025-03-24 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Voxcell BioInnovation Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Voxcell BioInnovation Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Voxcell BioInnovation Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Voxcell BioInnovation Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Voxcell BioInnovation Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Voxcell BioInnovation Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/voxcell-bioinnovation-inc-form-d-25000001